X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Marico Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs MARICO LTD - Comparison Results

MARICO LTD 
   Change

Marico derives 72% of its domestic revenues from edible oil and 20% from hair oils. It has two well-known domestic brands Parachute and Saffola and has acquired a clutch of international personal care brands such as 'Camelia', 'Aromatic' and 'Magnoli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES MARICO LTD AMAR REMEDIES/
MARICO LTD
 
P/E (TTM) x -0.5 50.5 - View Chart
P/BV x 0.1 17.3 0.3% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 AMAR REMEDIES   MARICO LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
MARICO LTD
Mar-18
AMAR REMEDIES/
MARICO LTD
5-Yr Chart
Click to enlarge
High Rs164348 47.2%   
Low Rs86284 30.3%   
Sales per share (Unadj.) Rs261.649.0 534.2%  
Earnings per share (Unadj.) Rs17.46.4 271.3%  
Cash flow per share (Unadj.) Rs22.37.1 313.9%  
Dividends per share (Unadj.) Rs04.25 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs100.720.0 504.7%  
Shares outstanding (eoy) m26.161,290.90 2.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.56.5 7.4%   
Avg P/E ratio x7.249.3 14.6%  
P/CF ratio (eoy) x5.644.5 12.6%  
Price / Book Value ratio x1.215.8 7.8%  
Dividend payout %066.3 0.0%   
Avg Mkt Cap Rs m3,270407,860 0.8%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1634,222 3.9%   
Avg. sales/employee Rs ThNM37,971.1-  
Avg. wages/employee Rs ThNM2,535.9-  
Avg. net profit/employee Rs ThNM4,969.7-  
INCOME DATA
Net Sales Rs m6,84463,222 10.8%  
Other income Rs m21846 2.5%   
Total revenues Rs m6,86564,068 10.7%   
Gross profit Rs m1,13111,378 9.9%  
Depreciation Rs m128891 14.4%   
Interest Rs m398162 246.1%   
Profit before tax Rs m62611,171 5.6%   
Minority Interest Rs m0-1 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1212,896 4.2%   
Profit after tax Rs m4558,275 5.5%  
Gross profit margin %16.518.0 91.8%  
Effective tax rate %19.325.9 74.6%   
Net profit margin %6.613.1 50.8%  
BALANCE SHEET DATA
Current assets Rs m4,90427,934 17.6%   
Current liabilities Rs m3,58114,576 24.6%   
Net working cap to sales %19.321.1 91.5%  
Current ratio x1.41.9 71.5%  
Inventory Days Days12487 142.5%  
Debtors Days Days10020 509.4%  
Net fixed assets Rs m1,6895,909 28.6%   
Share capital Rs m2621,291 20.3%   
"Free" reserves Rs m2,35824,474 9.6%   
Net worth Rs m2,63525,765 10.2%   
Long term debt Rs m507198 255.7%   
Total assets Rs m6,86240,815 16.8%  
Interest coverage x2.670.1 3.7%   
Debt to equity ratio x0.20 2,500.0%  
Sales to assets ratio x1.01.5 64.4%   
Return on assets %12.420.7 60.1%  
Return on equity %17.332.1 53.8%  
Return on capital %31.043.6 71.0%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2733,249 8.4%   
Fx outflow Rs m22,087 0.1%   
Net fx Rs m2711,161 23.3%   
CASH FLOW
From Operations Rs m-3135,545 -5.6%  
From Investments Rs m-489169 -289.6%  
From Financial Activity Rs m769-5,675 -13.5%  
Net Cashflow Rs m-3379 -41.1%  

Share Holding

Indian Promoters % 25.5 59.6 42.8%  
Foreign collaborators % 0.0 0.1 -  
Indian inst/Mut Fund % 9.2 2.6 353.8%  
FIIs % 0.0 31.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 6.7 974.6%  
Shareholders   13,061 37,128 35.2%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  GODREJ INDUSTRIES  BAJAJ CORP  GILLETTE INDIA  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

MARICO LTD Announces Quarterly Results (2QFY19); Net Profit Up 17.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MARICO LTD has posted a net profit of Rs 2 bn (up 17.6% YoY). Sales on the other hand came in at Rs 18 bn (up 19.6% YoY). Read on for a complete analysis of MARICO LTD's quarterly results.

MARICO LTD Announces Quarterly Results (1QFY19); Net Profit Up 10.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, MARICO LTD has posted a net profit of Rs 3 bn (up 10.3% YoY). Sales on the other hand came in at Rs 20 bn (up 19.8% YoY). Read on for a complete analysis of MARICO LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - P&G HYGIENE COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS